Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.
Liu J, Yang S, Cao B, Zhou G, Zhang F, Wang Y, Wang R, Zhu L, Meng Y, Hu C, Liang H, Lin X, Zhu K, Chen G, Luo KQ, Di L, Zhao Q.
Liu J, et al. Among authors: hu c.
J Hematol Oncol. 2021 Jan 29;14(1):21. doi: 10.1186/s13045-020-01024-8.
J Hematol Oncol. 2021.
PMID: 33514401
Free PMC article.